Webcasts
Bio-Techne at Cell & Gene Therapy Manufacturing and Commercialization 2023
Therapeutic ClassBio-Techne takes aim at CGT analytical bottlenecksBio-Techne takes aim at CGT analytical bottlenecks
Analytical bottlenecks are one of the biggest hurdles in bringing cell and gene therapies (CGTs) to fruition, says tools and services firm Bio-Techne.